Two noteworthy insider buys were reported recently. Helen Susan Kim purchased 835,000 shares of Aktis Oncology (AKTS) at $18.00 each, totaling $15.03M. The stock traded as high as $23.50, up 30.6% from her purchase. Carl J. Rickertsen bought $779,395 worth of Strategy (MSTR) at $155.88 per share, with the stock reaching $167.90, up 7.7%.

Read more at Nasdaq: Tuesday 1/13 Insider Buying Report: AKTS, MSTR